In the hyperplasia model, GPX3 inhibits AMPK and upregulates Nrf2 in the prostate cells to improve benign prostatic hyperplasia (Li et al., 2023a; Li et al., 2023b). The gene discussed is GPX3; the disease is benign prostatic hyperplasia.